Insider buying isn't evenly distributed. Where executives choose to deploy personal capital shifts with the cycle, and spring 2026 showed a clear rotation. Here's where CEOs were buying — and why aggregate sector activity is a softer signal than a single high-conviction purchase.
Reading the map, not the pin
A single CEO buy is a sharp, specific signal. Sector-level buying is blurrier — it tells you where conviction is pooling, not which name will work. Treat the sector view as context that frames individual signals, not as a trade on its own.
Financials led
The heaviest buying clustered in financials — asset managers and specialty insurers, where executives often have the clearest line of sight into book value versus price. When a leader in that group buys after a selloff, the conviction factor in our scoring tends to light up.
Healthcare stayed active
Healthcare buying continued, concentrated in small- and mid-cap names ahead of catalysts. This is exactly the corner where the information edge is widest — less analyst coverage, more asymmetry — a pattern we covered in small-cap insider buying.
Where it went quiet
Consumer names saw the least open-market buying. Quiet sectors aren't a sell signal — insiders simply weren't stepping in with personal capital, which is its own (weak) piece of information.
How we use the rotation
- As context for individual signals, never as a standalone trade.
- To sanity-check clusters: several buys in one sector raise the odds it's a theme, not a coincidence.
- To stay humble — sector tilts mean-revert, and chasing last quarter's hot group is a classic mistake.
Every signal that cleared our scoring this spring, regardless of sector, is tracked the same way on the track record. Not financial advice — sector commentary is educational context only.